NCT03505281View on ClinicalTrials.gov

Evaluation of a Functional Lymphocyte Test (QuantiFERON Monitor®) as a Prognostic Marker for Acute Community-acquired Pneumonia

CompletedOBSERVATIONAL

Enrollment

230

Participants

Timeline

Start Date

November 5, 2018

Primary Completion Date

July 30, 2025

Study Completion Date

July 30, 2025

Conditions

Pneumonia

Interventions

BIOLOGICAL

Blood samples

"Patients:~* 1 tube of 4 ml blood (Lithium Heparinate)~* 3 tubes of 7 ml blood (EDTA)~* 2 tubes of 7 ml blood (EDTA) for 20 NET Covid patients~Healthy volunteers:~* 1 tube of 4 ml blood (Lithium Heparinate)~* 3 tubes of 7 ml of blood (EDTA)~* 1 tube of 4 ml (citrate)"

Trial Locations (1)

21000

Chu Dijon Bourogne, Dijon

All Listed Sponsors

lead

Centre Hospitalier Universitaire Dijon

OTHER

NCT03505281 - Evaluation of a Functional Lymphocyte Test (QuantiFERON Monitor®) as a Prognostic Marker for Acute Community-acquired Pneumonia | Biotech Hunter | Biotech Hunter